JP2001354545A - External skin preparation and external skin preparation composition - Google Patents
External skin preparation and external skin preparation compositionInfo
- Publication number
- JP2001354545A JP2001354545A JP2000180375A JP2000180375A JP2001354545A JP 2001354545 A JP2001354545 A JP 2001354545A JP 2000180375 A JP2000180375 A JP 2000180375A JP 2000180375 A JP2000180375 A JP 2000180375A JP 2001354545 A JP2001354545 A JP 2001354545A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- skin
- whitening
- fruit
- external skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 55
- 239000000203 mixture Substances 0.000 title claims abstract description 38
- 239000000284 extract Substances 0.000 claims abstract description 126
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims abstract description 33
- 244000298697 Actinidia deliciosa Species 0.000 claims abstract description 33
- 239000002260 anti-inflammatory agent Substances 0.000 claims abstract description 11
- 229940121363 anti-inflammatory agent Drugs 0.000 claims abstract description 11
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 11
- 239000012190 activator Substances 0.000 claims abstract description 10
- 239000003112 inhibitor Substances 0.000 claims abstract description 10
- 239000013543 active substance Substances 0.000 claims abstract 2
- 235000013399 edible fruits Nutrition 0.000 claims description 31
- 241001107098 Rubiaceae Species 0.000 claims description 10
- 230000000844 anti-bacterial effect Effects 0.000 claims description 9
- 239000003906 humectant Substances 0.000 claims description 9
- 239000003899 bactericide agent Substances 0.000 claims description 8
- 239000007844 bleaching agent Substances 0.000 claims description 6
- 241000222518 Agaricus Species 0.000 claims description 2
- 240000007154 Coffea arabica Species 0.000 abstract description 34
- 235000007460 Coffea arabica Nutrition 0.000 abstract description 34
- 239000003795 chemical substances by application Substances 0.000 abstract description 14
- 230000002401 inhibitory effect Effects 0.000 abstract description 7
- 230000003078 antioxidant effect Effects 0.000 abstract description 6
- 230000007721 medicinal effect Effects 0.000 abstract description 5
- 241000219068 Actinidia Species 0.000 abstract description 3
- 241000219066 Actinidiaceae Species 0.000 abstract description 2
- 230000006866 deterioration Effects 0.000 abstract description 2
- 230000003020 moisturizing effect Effects 0.000 abstract description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract 2
- 239000007854 depigmenting agent Substances 0.000 abstract 2
- 229940068517 fruit extracts Drugs 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000002087 whitening effect Effects 0.000 description 29
- 210000004027 cell Anatomy 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- -1 packs Substances 0.000 description 13
- 230000002500 effect on skin Effects 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 235000006708 antioxidants Nutrition 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 230000001747 exhibiting effect Effects 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 206010014970 Ephelides Diseases 0.000 description 7
- 208000003351 Melanosis Diseases 0.000 description 7
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 7
- 230000008099 melanin synthesis Effects 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 206010042496 Sunburn Diseases 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 239000002674 ointment Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 4
- 208000001382 Experimental Melanoma Diseases 0.000 description 4
- 208000012641 Pigmentation disease Diseases 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000019612 pigmentation Effects 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 3
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 3
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000010419 fine particle Substances 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 210000002826 placenta Anatomy 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 229940042585 tocopherol acetate Drugs 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 2
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 2
- 235000005340 Asparagus officinalis Nutrition 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 239000011703 D-panthenol Substances 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- 235000004866 D-panthenol Nutrition 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 241001071795 Gentiana Species 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 229960003949 dexpanthenol Drugs 0.000 description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- QHNVWXUULMZJKD-UHFFFAOYSA-N 3,4-didehydroretinal Chemical compound O=CC=C(C)C=CC=C(C)C=CC1=C(C)C=CCC1(C)C QHNVWXUULMZJKD-UHFFFAOYSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298715 Actinidia chinensis Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 244000003416 Asparagus officinalis Species 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 235000011960 Brassica ruvo Nutrition 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 241000219357 Cactaceae Species 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 241000252229 Carassius auratus Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000723377 Coffea Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 240000000731 Fagus sylvatica Species 0.000 description 1
- 235000010099 Fagus sylvatica Nutrition 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 101000879758 Homo sapiens Sjoegren syndrome nuclear autoantigen 1 Proteins 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 240000005074 Hymenocallis caribaea Species 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000219745 Lupinus Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 235000017879 Nasturtium officinale Nutrition 0.000 description 1
- 240000005407 Nasturtium officinale Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 239000009724 Salvia extract Substances 0.000 description 1
- 235000018735 Sambucus canadensis Nutrition 0.000 description 1
- 244000151637 Sambucus canadensis Species 0.000 description 1
- 241000580955 Sapindus mukorossi Species 0.000 description 1
- 241000555745 Sciuridae Species 0.000 description 1
- 102100037330 Sjoegren syndrome nuclear autoantigen 1 Human genes 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- PAUSGZCRNOTKPK-UHFFFAOYSA-N [5-hydroxy-6-methyl-4-(octanoyloxymethyl)pyridin-3-yl]methyl octanoate Chemical compound CCCCCCCC(=O)OCC1=CN=C(C)C(O)=C1COC(=O)CCCCCCC PAUSGZCRNOTKPK-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 244000193174 agave Species 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940089116 arnica extract Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 235000019206 astragalus extract Nutrition 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 235000007123 blue elder Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 235000020230 cinnamon extract Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000007124 elderberry Nutrition 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- 229940106579 hops extract Drugs 0.000 description 1
- 239000001906 humulus lupulus l. absolute Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 150000002814 niacins Chemical class 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229940067631 phospholipid Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 150000003227 pyridoxines Chemical class 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- KJCLYACXIWMFCC-UHFFFAOYSA-M sodium;5-benzoyl-4-hydroxy-2-methoxybenzenesulfonate Chemical compound [Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 KJCLYACXIWMFCC-UHFFFAOYSA-M 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、マタタビ科、マタ
タビ属のキウイフルーツ果実の抽出物およびアカネ科、
コーヒーノキ属のコーヒーノキ種子の抽出物を含有する
皮膚外用剤およびこれに他の薬効成分を組み合わせた皮
膚外用剤組成物に関するものである。[0001] The present invention relates to an extract of the family Actinaceae, an extract of the fruit of the Kiwi fruit of the genus Actinaceae and a family of Rubiaceae,
The present invention relates to a skin external preparation containing an extract of coffee tree seeds of the genus Coffee tree, and a skin external preparation composition obtained by combining the same with other medicinal ingredients.
【0002】[0002]
【従来の技術】従来より、乳液、クリーム、化粧水、パ
ック、洗浄料、分散液、軟膏、外用液剤等の皮膚外用剤
には、これらに所定の薬効を付与することを目的として
種々の薬効成分が加えられている。例えば、日焼け等に
より生じる皮膚の黒化、色素沈着により生ずるシミ、ソ
バカス等の現象を防止するために、アスコルビン酸やグ
ルタチオン、ハイドロキノン等の美白剤が加えられてい
る。2. Description of the Related Art Conventionally, skin external preparations such as emulsions, creams, lotions, packs, cleansing agents, dispersions, ointments, and external preparations have been treated with various medicinal effects in order to impart predetermined medicinal effects thereto. Ingredients have been added. For example, whitening agents such as ascorbic acid, glutathione, and hydroquinone have been added to prevent phenomena such as darkening of the skin caused by sunburn, pigmentation, and spots and freckles caused by pigmentation.
【0003】[0003]
【発明が解決しようとする課題】しかしながら、これら
の美白剤では、美白・美肌効果が十分でなかったり、あ
るいは、製剤中で変質するなどして所期の薬効が得られ
ない場合が多く、その改善が望まれていた。However, in many cases, these whitening agents do not have sufficient whitening / skinning effects, or do not have the desired medicinal effect due to deterioration in the preparation. Improvement was desired.
【0004】[0004]
【課題を解決するための手段】本発明者らは、優れた薬
効作用を有し、皮膚外用剤の薬効成分として使用するこ
とができる天然成分について、鋭意検索を行った結果、
マタタビ科、マタタビ属のキウイフルーツ果実の抽出物
およびアカネ科、コーヒーノキ属のコーヒーノキ種子の
抽出物を組み合わせることにより、高いメラニン生成抑
制作用が得られ、優れた効果を有する美白・美肌成分で
あることを見出した。そして、これらの抽出物は、更
に、他の薬効成分と組み合わせることにより皮膚外用剤
組成物としてより優れた効果が得られることを見出し、
本発明を完成した。Means for Solving the Problems The present inventors have conducted an intensive search for natural ingredients that have excellent medicinal properties and can be used as medicinal ingredients in skin external preparations.
It is a whitening / skin component that has a high melanin production inhibitory effect and is an excellent effect by combining the extract of the fruit of the genus Actinidia, the genus Kiwi fruit of the genus Actinidia, and the extract of the seeds of the genus Rubiaceae and the genus Coffeefruit. Was found. And these extracts, furthermore, found that a more excellent effect as a skin external preparation composition can be obtained by combining with other medicinal ingredients,
The present invention has been completed.
【0005】すなわち本発明は、次の成分(A)および
(B) (A)マタタビ科、マタタビ属のキウイフルーツの果実
抽出物 (B)アカネ科コーヒーノキ属のコーヒーノキ種子の抽
出物を含有することを特徴とする、優れた美白・美肌効
果を有し、色素沈着を改善するとともに肌の透明感を向
上する効果のある皮膚外用剤を提供するものである。More specifically, the present invention comprises the following components (A) and (B): (A) a fruit extract of a Kiwifruit belonging to the family Rubiaceae and the genus Rubiaceae; (B) an extract of coffee tree seeds belonging to the genus Rubiaceae; It is intended to provide a skin external preparation having an excellent whitening / beautiful skin effect, improving pigmentation and improving skin transparency.
【0006】また、本発明は、次の成分(A)、(B)
および(C) (A)マタタビ科、マタタビ属のキウイフルーツ果実の
抽出物 (B)アカネ科、コーヒーノキ属のコーヒーノキ種子の
抽出物 (C)美白剤、抗酸化剤、抗炎症剤、紫外線防止剤、殺
菌剤、保湿剤及び細胞賦活剤から選ばれる薬効剤の一種
又は二種以上を含有することを特徴とする皮膚外用剤組
成物を提供するものである。Further, the present invention provides the following components (A) and (B)
And (C) (A) Extract of the fruit of the genus Matabiaceae, Kiwifruit of the genus Agaricus (B) Extract of the seeds of the seeds of the genus Rubiaceae and of the genus Coffeefruit (C) Whitening agents, antioxidants, anti-inflammatory agents, and UV inhibitors The present invention provides a composition for external use on the skin, characterized in that it contains one or more medicinal agents selected from the group consisting of a bactericide, a humectant and a cell activator.
【0007】[0007]
【発明の実施の形態】本発明の(A)成分であるキウイ
フルーツ果実の抽出物は、常法に従いキウイフルーツの
果実を抽出することにより得られる。この原料であるキ
ウイフルーツは、マタタビ科マタタビ属に属し、学名は
Actinidia chinensis Planch(Actinidiaceae)で、ニ
ュージーランド原産のものである。BEST MODE FOR CARRYING OUT THE INVENTION The extract of kiwifruit fruit which is the component (A) of the present invention can be obtained by extracting the fruit of kiwifruit according to a conventional method. Kiwifruit, which is the raw material, belongs to the genus Matabida, and its scientific name is
Actinidia chinensis Planch (Actinidiaceae), native to New Zealand.
【0008】一方、コーヒーノキ種子の抽出物は、常法
に従いコーヒーノキ種子を抽出することにより得られ
る。この原料であるコーヒーノキは、アカネ科コーヒー
ノキ属に属し、学名は、Coffea arabica Linneまたはそ
の同属植物(Rubiaceae)で、南米原産のものである。
しかし本発明で使用する成分(A)、成分(B)のいず
れの抽出物を製造するに当たっても、その種類や産地は
特に限定されない。[0008] On the other hand, an extract of coffee tree seeds is obtained by extracting coffee tree seeds according to a conventional method. This raw material, coffee tree, belongs to the genus Rubiaceae, and its scientific name is Coffea arabica Linne or its congener plant (Rubiaceae), which is native to South America.
However, in producing the extract of either the component (A) or the component (B) used in the present invention, the type and place of production are not particularly limited.
【0009】上記キウイフルーツの果実またはコーヒー
ノキの種子からの成分(A)または成分(B)の抽出物
の調整法は、特に限定されるものではないが、例えばこ
れらを乾燥又は乾燥せずに裁断した後、低温もしくは常
温〜加温下で溶剤により抽出する方法を挙げることがで
きる。The method for preparing the extract of component (A) or component (B) from the fruit of the kiwifruit or the seeds of coffee tree is not particularly limited. For example, the extract may be dried or cut without drying. After that, a method of extracting with a solvent at a low temperature or at a normal temperature to a heating temperature can be mentioned.
【0010】抽出溶媒としては、一般的には水、低級1
価アルコール類(メタノール、エタノール、1−プロパ
ノール、2−プロパノール、1−ブタノール、2−ブタ
ノール等)、液状多価アルコール(プロピレングリコー
ル、1,3−ブチレングリコール等)、低級アルキルエ
ステル(酢酸エチル等)、炭化水素(ベンゼン、ヘキサ
ン、ペンタン等)、ケトン類(アセトン、メチルエチル
ケトン等)、エーテル類(ジエチルエーテル、テトラヒ
ドロフラン、ジプロピルエーテル等)、アセトニトリル
等が挙げられる。As an extraction solvent, generally, water, low-grade 1
Polyhydric alcohols (methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, etc.), liquid polyhydric alcohols (propylene glycol, 1,3-butylene glycol, etc.), lower alkyl esters (ethyl acetate, etc.) ), Hydrocarbons (benzene, hexane, pentane, etc.), ketones (acetone, methyl ethyl ketone, etc.), ethers (diethyl ether, tetrahydrofuran, dipropyl ether, etc.), acetonitrile and the like.
【0011】また、好ましい抽出方法の例としては、含
水濃度0〜100容量%のエチルアルコールまたは1,
3−ブチレングリコールを用い、室温にて1〜5日間抽
出を行ったのち濾過し、得られた濾液をさらに1週間ほ
ど放置して熟成させ、再び濾過を行う方法が挙げられ
る。As a preferred example of the extraction method, ethyl alcohol having a water content of 0 to 100% by volume or 1, 1 vol.
Extraction is performed at room temperature for 1 to 5 days using 3-butylene glycol, followed by filtration, and the obtained filtrate is left to mature for about one week, followed by filtration again.
【0012】本発明の皮膚外用剤における、成分(A)
および成分(B)の含有量は、それぞれの乾燥固形分と
して好ましくは0.00001〜5質量%(以下単に
「%」で示す)であり、より好ましくは0.0001〜
2%である。この範囲内であれば、成分(A)および成
分(B)を安定に配合することができ、かつ高い美白、
美肌効果を発揮することができる。また、成分(A)お
よび/または成分(B)を抽出液として使用する場合
は、溶質である乾燥固形分の含有量が上記範囲内であれ
ば、その抽出液濃度は何ら限定されるものではない。Component (A) in the external preparation for skin of the present invention
And the content of the component (B) is preferably 0.00001 to 5% by mass (hereinafter simply referred to as "%") as a dry solid content, and more preferably 0.0001 to 5%.
2%. Within this range, the component (A) and the component (B) can be stably compounded and have high whitening,
A beautiful skin effect can be exhibited. When the component (A) and / or the component (B) is used as an extract, the concentration of the extract is not limited as long as the content of the dry solid as a solute is within the above range. Absent.
【0013】本発明の成分(A)および成分(B)は、
これを美白・美肌成分として常法に従い、通常の皮膚外
用剤に使用される種々の形態の基剤に配合し、製剤化す
ることにより皮膚外用剤を得ることができるが、更に他
の薬効成分と組み合わせることにより、より美白・美肌
効果の優れた皮膚外用剤が得られる。The components (A) and (B) of the present invention comprise:
According to a conventional method as a skin whitening / beautifying skin component, it can be blended with various forms of bases used in normal skin external preparations and formulated to give a skin external preparation. By combining with the above, an external preparation for skin with more excellent whitening and skin effect can be obtained.
【0014】また、本発明において、成分(A)および
成分(B)と組み合わされて使用される他の薬効成分
(成分(C))は、美白剤、抗酸化剤、抗炎症剤、紫外
線防止剤、殺菌剤、保湿剤及び細胞賦活剤から選ばれる
薬効剤である。具体的な成分(C)の例としては、それ
ぞれ以下に示すものが挙げられる。Further, in the present invention, other medicinal components (component (C)) used in combination with the components (A) and (B) include a whitening agent, an antioxidant, an anti-inflammatory agent, and an ultraviolet ray preventing agent. It is a medicinal agent selected from agents, fungicides, humectants and cell activators. Specific examples of the component (C) include the following.
【0015】( 美 白 剤 )美白剤としては、ビタミン
C及びその誘導体並びにそれらの塩、胎盤抽出物、甘草
抽出物、ヨクイニン抽出物、アスパラガス抽出物、エイ
ジツ抽出物、キイチゴ抽出物、クジン抽出物、ケイケッ
トウ抽出物、ゴカヒ抽出物、コメヌカ抽出物、小麦胚芽
抽出物、サイシン抽出物、サンザシ抽出物、シラユリ抽
出物、シャクヤク抽出物、大豆抽出物、緑茶、紅茶、ウ
ーロン茶等の茶抽出物、糖蜜抽出物、ビャクレン抽出
物、ブナの芽抽出物、ブドウ抽出物、ホップ抽出物、マ
イカイカ抽出物、モッカ抽出物及び羅漢果抽出物、オウ
ゴン抽出物、海藻抽出物等が挙げられる。これらの美白
剤のうち、特に好ましいものとしては、ビタミンC及び
その誘導体並びにそれらの塩、胎盤抽出物が挙げられ
る。(Whitening agent) As a whitening agent, vitamin C and its derivatives and salts thereof, placenta extract, licorice extract, yokuinin extract, asparagus extract, oedum extract, raspberry extract, jinjin extract Tea extract, such as stuff, cinnamon extract, kokahi extract, rice bran extract, wheat germ extract, saishin extract, hawthorn extract, white lily extract, peony extract, soybean extract, green tea, black tea, oolong tea, Molasses extract, liquorice extract, beech sprouts extract, grape extract, hops extract, squid extract, mocca extract and arhat extract, squirrel extract, seaweed extract and the like. Among these whitening agents, particularly preferred are vitamin C and its derivatives, salts thereof, and placental extracts.
【0016】( 抗 酸 化 剤 )また抗酸化剤として
は、マンニトール、ルチン及びその誘導体、クエルセチ
ン、リン脂質、ビタミンA類(ベータカロチン、アスタ
キサンチン、デヒドロレチナール、カロチン等のカロチ
ノイド等)、ピリドキシン類(塩酸ピリドキシン、ピリ
ドキシンジオクタノエート等)、ニコチン酸類(ニコチ
ン酸アミド、ニコチン酸ベンジル等)、ジブチルヒドロ
キシトルエン(BHT)、ブチルヒドロキシアニソール
(BHA)、ビタミンE及びその誘導体並びにそれらの
塩、ニンジン抽出物、メリッサ抽出物、ヤシャジツ抽出
物等が挙げられる。これらの抗酸化剤のうち、特に好ま
しいものとしては、ビタミンE及びその誘導体並びにそ
れらの塩が挙げられる。(Antioxidants) Examples of antioxidants include mannitol, rutin and its derivatives, quercetin, phospholipids, vitamins A (carotenoids such as beta-carotene, astaxanthin, dehydroretinal, carotene, etc.), pyridoxines ( Pyridoxine hydrochloride, pyridoxine dioctanoate, etc.), nicotinic acids (nicotinamide, benzyl nicotinate, etc.), dibutylhydroxytoluene (BHT), butylhydroxyanisole (BHA), vitamin E and its derivatives and their salts, carrot extraction , Melissa extract, Jasazi extract and the like. Among these antioxidants, particularly preferred ones include vitamin E and its derivatives and salts thereof.
【0017】( 抗 炎 症 剤 )抗炎症剤としては、コ
ンドロイチン硫酸及びその誘導体、アラントイン、アル
ニカ抽出物、オトギリソウ抽出物、オウバク抽出物、キ
ンギンカ抽出物、クレソン抽出物、コンフリー抽出物、
サルビア抽出物、シコン抽出物、シラカバ抽出物、トウ
キンセンカ抽出物、ニワトコ抽出物、ホオウ抽出物、ム
クロジ抽出物、ユーカリ抽出物、レンゲソウ抽出物、グ
リチルリチン酸、グリチルレチン酸及びそれらの誘導体
並びにそれらの塩、アロエ抽出物、シソ抽出物、ヨモギ
抽出物、カミツレ抽出物等が挙げられる。これらの抗炎
症剤のうち、特に好ましいものとしては、グリチルリチ
ン酸、グリチルレチン酸及びそれらの誘導体並びにそれ
らの塩が挙げられる。(Anti-inflammatory agent) As anti-inflammatory agents, chondroitin sulfate and its derivatives, allantoin, arnica extract, hypericum extract, oak extract, goldfish extract, watercress extract, comfrey extract,
Salvia extract, Shikon extract, Birch extract, Calendula extract, Elderberry extract, Asparagus extract, Mukuroji extract, Eucalyptus extract, Astragalus extract, Glycyrrhizic acid, Glycyrrhetinic acid and derivatives thereof and salts thereof , Aloe extract, perilla extract, mugwort extract, chamomile extract and the like. Among these anti-inflammatory agents, particularly preferable ones include glycyrrhizic acid, glycyrrhetinic acid and their derivatives and salts thereof.
【0018】( 紫 外 線 防 止 剤 )紫外線防止剤と
しては、2−ヒドロキシ−4−メトキシベンゾフェノン
−5−スルホン酸ナトリウム、パラメトキシケイ皮酸−
2−エチルヘキシル、オキシベンゾン、4−tert−
ブチル−4’−メトキシジベンゾイルメタン、酸化チタ
ン、微粒子酸化チタンおよび酸化亜鉛等があげられる。
これらの紫外線防止剤のうち、特に好ましいものとして
は、パラメトキシケイ皮酸−2−エチルヘキシル、酸化
チタン、微粒子酸化チタン、酸化亜鉛が挙げられる。(Ultraviolet ray inhibitor) As ultraviolet ray inhibitors, sodium 2-hydroxy-4-methoxybenzophenone-5-sulfonate, paramethoxycinnamic acid-
2-ethylhexyl, oxybenzone, 4-tert-
Butyl-4'-methoxydibenzoylmethane, titanium oxide, fine particle titanium oxide, zinc oxide and the like.
Among these ultraviolet inhibitors, particularly preferred are 2-ethylhexyl paramethoxycinnamate, titanium oxide, fine particle titanium oxide, and zinc oxide.
【0019】( 殺 菌 剤 )殺菌剤としては、サリチル
酸およびその塩、イソプロピルメチルフェノール、ヒノ
キチオール、感光素等が挙げられる。これらの殺菌剤の
うち、特に好ましいものとして、サリチル酸およびその
塩、イソプロピルメチルフェノールが挙げられる。(Bactericide) Examples of the bactericide include salicylic acid and salts thereof, isopropylmethylphenol, hinokitiol, and photosensitizer. Of these fungicides, particularly preferred are salicylic acid and its salts, and isopropylmethylphenol.
【0020】( 保 湿 剤 )また保湿剤としては、アル
カリ単純温泉水、深層水、ムコ多糖類またはそれらの誘
導体、糖類、セラミド、尿素、D−パンテノール、ゲン
チアナ抽出物、サボテン抽出物、ゼニアオイ抽出物、ハ
ウチワマメ抽出物、ヨクイニン抽出物、プルーン抽出
物、ブッチャーズブルーム抽出物、マロニエ抽出物等が
挙げられる。これらの保湿剤のうち、特に好ましいもの
としては、深層水、D−パンテノール、ゲンチアナ抽出
物、プルーン抽出物が挙げられる。(Humectant) Examples of the humectant include alkaline hot spring water, deep water, mucopolysaccharides or derivatives thereof, saccharides, ceramide, urea, D-panthenol, gentian extract, cactus extract, and mallow. Extracts, lupine bean extracts, yokunin extracts, prune extracts, Butchers bloom extracts, marronnier extracts and the like. Among these humectants, particularly preferred are deep water, D-panthenol, gentian extract, and prune extract.
【0021】( 細 胞 賦 活 剤 )細胞賦活剤として
は、ビタミンAおよびその誘導体、クエン酸、乳酸、酒
石酸、リンゴ酸、グリコール酸、コハク酸、セリン、グ
ルタミン酸、ヒドロキシプロリン、テアニン、ピロリド
ンカルボン酸、酵母抽出物、乳酸菌抽出物、ビフィズス
菌抽出物、醗酵代謝抽出物等が挙げられる。これらの細
胞賦活剤のうち、特に好ましいものとしては、ビタミン
Aおよびその誘導体、クエン酸、乳酸、リンゴ酸、セリ
ン、ピロリドンカルボン酸が挙げられる。(Cell activator) Examples of cell activators include vitamin A and its derivatives, citric acid, lactic acid, tartaric acid, malic acid, glycolic acid, succinic acid, serine, glutamic acid, hydroxyproline, theanine, and pyrrolidone carboxylic acid. , Yeast extract, lactic acid bacteria extract, bifidobacterium extract, fermentation metabolic extract and the like. Among these cell activators, particularly preferred are vitamin A and its derivatives, citric acid, lactic acid, malic acid, serine, and pyrrolidone carboxylic acid.
【0022】本発明の皮膚外用剤組成物における上記成
分(C)の含有量は、薬効剤の種類により相違するが、
以下に示す範囲とすることが好ましい。この範囲であれ
ば、成分(A)および成分(B)と組み合わせた場合、
製剤中の成分(A)および成分(B)の抽出物の経時安
定性に影響を及ぼすことがなく、より高い美白・美肌効
果を発揮させることができる。The content of the component (C) in the composition for external use on skin of the present invention varies depending on the kind of the medicinal agent.
It is preferable to set the following range. Within this range, when combined with component (A) and component (B),
It is possible to exhibit higher whitening and beautiful skin effect without affecting the temporal stability of the extract of the components (A) and (B) in the preparation.
【0023】すなわち、本発明の皮膚外用剤組成物にお
いて、成分(C)として美白剤を配合する場合の配合量
は、好ましくは0.00001〜10%であり、より好
ましくは0.0001〜5%の範囲である。抽出物を抽
出液のまま用いる場合は乾燥固形分としてこの範囲であ
れば問題ない。この範囲であればより優れた美白・美肌
効果を示し、かつ、使用感の良好な皮膚外用剤組成物が
得られる。That is, in the skin external preparation composition of the present invention, the blending amount of the whitening agent as the component (C) is preferably 0.00001 to 10%, more preferably 0.0001 to 5%. % Range. When the extract is used as it is, there is no problem as long as the dry solid content is within this range. Within this range, a skin external preparation composition exhibiting more excellent whitening / skinning effects and having a good feeling in use can be obtained.
【0024】また、本発明の皮膚外用剤組成物におい
て、成分(C)として抗酸化剤を配合する場合の配合量
は、好ましくは0.00001〜5%、より好ましくは
0.0001〜3%の範囲である。抽出物を抽出液のま
ま用いる場合は、乾燥固形分としてこの範囲であれば問
題ない。この範囲であればより優れた抗酸化効果の発現
がみられ、かつ、優れた美白・美肌効果を示す皮膚外用
剤組成物が得られる。In the composition for external preparation for skin of the present invention, the amount of the antioxidant to be added as component (C) is preferably 0.00001 to 5%, more preferably 0.0001 to 3%. Range. When the extract is used as it is, there is no problem as long as the dry solid content is within this range. Within this range, a more excellent antioxidant effect can be obtained, and a skin external preparation composition exhibiting excellent whitening and skin beautiful effects can be obtained.
【0025】更に、本発明の皮膚外用剤組成物におい
て、成分(C)として抗炎症剤を配合する場合の配合量
としては、0.00001〜5%の範囲が好ましく、よ
り好ましくは0.0001〜3%の範囲である。抽出物
を抽出液のまま用いる場合は、乾燥固形分としてこの範
囲であれば問題ない。この範囲であれば優れた抗炎症効
果がみられ、かつ、優れた美白・美肌効果を示す皮膚外
用剤組成物が得られる。Further, in the skin external preparation composition of the present invention, the compounding amount when the anti-inflammatory agent is added as the component (C) is preferably in the range of 0.00001 to 5%, more preferably 0.0001%. 33%. When the extract is used as it is, there is no problem as long as the dry solid content is within this range. Within this range, a skin external preparation composition exhibiting an excellent anti-inflammatory effect and exhibiting excellent whitening and skin effect can be obtained.
【0026】更にまた、本発明の皮膚外用剤組成物にお
いて、成分(C)として紫外線防止剤を配合する場合の
配合量としては、好ましくは0.0001〜20%、よ
り好ましくは0.001〜10%の範囲である。この範
囲であればより優れた紫外線防止効果を発現し、かつ、
優れた美白・美肌効果を示す皮膚外用剤組成物が得られ
る。Furthermore, in the skin external preparation composition of the present invention, when the ultraviolet ray inhibitor is added as the component (C), the amount is preferably 0.0001 to 20%, more preferably 0.001 to 20%. It is in the range of 10%. If it is in this range, it will exhibit a better UV protection effect, and
A skin external preparation composition exhibiting excellent whitening and skin effect can be obtained.
【0027】一方、本発明の皮膚外用剤組成物におい
て、成分(C)として殺菌剤を配合する場合の配合量と
しては、好ましくは0.00001〜5%の範囲であ
り、より好ましくは0.0001〜3%の範囲である。
この範囲であればより優れた殺菌効果を発現し、かつ、
優れた美白・美肌効果を示す皮膚外用剤組成物が得られ
る。On the other hand, in the skin external preparation composition of the present invention, the compounding amount when a bactericide is compounded as the component (C) is preferably in the range of 0.00001 to 5%, more preferably 0.1 to 5%. It is in the range of 000-1%.
If it is in this range, it will exhibit a better bactericidal effect, and
A skin external preparation composition exhibiting excellent whitening and skin effect can be obtained.
【0028】加えて、本発明の皮膚外用剤組成物におい
て、成分(C)として保湿剤を配合する場合の配合量と
しては、好ましくは0.00001〜50%の範囲であ
り、より好ましくは0.0001〜20%の範囲であ
る。この範囲であればより優れた保湿効果を発現し、か
つ、優れた美白・美肌効果を示す皮膚外用剤組成物が得
られる。In addition, when the humectant is added as the component (C) in the skin external preparation composition of the present invention, the compounding amount is preferably in the range of 0.00001 to 50%, and more preferably 0%. 0.0001 to 20%. Within this range, a skin external preparation composition that exhibits a more excellent moisturizing effect and also has an excellent whitening and skin effect can be obtained.
【0029】更に加えて、本発明の皮膚外用剤組成物に
おいて、成分(C)として細胞賦活剤を配合する場合の
配合量としては、好ましくは0.00001〜5%の範
囲であり、より好ましくは0.0001〜3%の範囲で
ある。なお、抽出物を抽出液のまま用いる場合は、乾燥
固形分としてこの範囲であれば問題ない。この範囲であ
ればより優れた細胞賦活効果を発現し、かつ、優れた美
白・美肌効果を示す皮膚外用剤組成物が得られる。In addition, in the skin external preparation composition of the present invention, when the cell activator is added as the component (C), the amount is preferably in the range of 0.00001 to 5%, more preferably. Is in the range of 0.0001 to 3%. When the extract is used as it is, there is no problem as long as the dry solid content is within this range. Within this range, a skin external preparation composition exhibiting a more excellent cell activating effect and exhibiting an excellent whitening and skin effect can be obtained.
【0030】これらの成分(C)、すなわち美白剤、抗
酸化剤、抗炎症剤、紫外線防止剤、殺菌剤、保湿剤およ
び細胞賦活剤は、その一種又は二種以上を組み合わせて
用いることができる。These components (C), ie, a whitening agent, an antioxidant, an anti-inflammatory agent, an ultraviolet ray inhibitor, a bactericide, a humectant and a cell activator can be used alone or in combination of two or more. .
【0031】上記の成分(A)、成分(B)および成分
(C)を組み合わせた皮膚外用剤組成物も、常法に従
い、必須成分である成分(A)、成分(B)および成分
(C)とを通常の皮膚外用剤として知られる種々の形態
の基剤に配合し、製剤化することにより調製することが
できる。A skin external preparation composition obtained by combining the above components (A), (B) and (C) is also prepared according to a conventional method, as essential components (A), (B) and (C). ) Is mixed with various types of bases known as usual external preparations for the skin, and formulated into a formulation.
【0032】皮膚外用剤および皮膚外用剤組成物の配合
形態の例としては、特に限定されず、例えば、乳液、ク
リーム、化粧水、パック、洗浄料、メーキャップ化粧
料、分散液および軟膏などの化粧料や外用医薬品等とす
ることができる。Examples of the form of the external preparation for skin and the composition for external preparation for skin are not particularly limited, and examples thereof include cosmetics such as emulsions, creams, lotions, packs, detergents, makeup cosmetics, dispersions and ointments. Drugs and external medicines.
【0033】また、皮膚外用剤および皮膚外用剤組成物
の形態に応じ、上記必須成分以外に通常化粧品や医薬品
等の皮膚外用剤等に用いられる成分、例えば、精製水、
低級アルコール、多価アルコール、油性成分、粉体、界
面活性剤、増粘剤、色材、防腐剤および香料等を用いる
ことができる。Further, depending on the form of the external preparation for skin and the external preparation composition for skin, in addition to the above essential components, components usually used in external preparations for skin such as cosmetics and pharmaceuticals, for example, purified water,
Lower alcohols, polyhydric alcohols, oily components, powders, surfactants, thickeners, coloring materials, preservatives, fragrances, and the like can be used.
【0034】[0034]
【実施例】次に参考例、試験例及び実施例を挙げて本発
明を更に詳細に説明するが、本発明はこれらになんら制
約されるものではない。EXAMPLES Next, the present invention will be described in more detail with reference to Reference Examples, Test Examples and Examples, but the present invention is not limited thereto.
【0035】参 考 例 1 キウイフルーツ果実の抽出物の製造:キウイフルーツ果
実10gに、水30mlを加え、室温にて3日間抽出を
行ったのち濾過してキウイフルーツ果実の抽出物を得
た。この抽出物の乾燥固形分は1.5%であった。Reference Example 1 Preparation of Kiwifruit Fruit Extract: Kiwifruit fruit extract was obtained by adding 30 ml of water to 10 g of kiwifruit fruit, extracting at room temperature for 3 days, and filtering. The dry solids content of this extract was 1.5%.
【0036】参 考 例 2 コーヒーノキ種子の抽出物の製造:コーヒーノキ種子1
0gに、70容量%エチルアルコール100mlを加
え、室温にて3日間抽出を行ったのち濾過してコーヒー
ノキ種子の抽出物を得た。このときコーヒーノキ種子の
抽出物の乾燥固形分は1.9%であった。REFERENCE EXAMPLE 2 Production of an extract of coffee tree seed: coffee tree seed 1
To 0 g, 100 ml of 70% by volume ethyl alcohol was added, extracted at room temperature for 3 days, and then filtered to obtain an extract of coffee tree seeds. At this time, the dry solid content of the extract of coffee tree seeds was 1.9%.
【0037】試 験 例 1 細胞培養によるメラニン生成抑制及び細胞生存率試験:
試験細胞としてマウス由来のB16メラノーマ培養細胞
を使用し、メラニン生成抑制および細胞生存率を調べ
た。2枚の6穴シャーレに10%FBS添加MEM培地
(日水製薬社製)を適量とり、B16メラノーマ細胞を
播種し、37℃、二酸化炭素濃度5%中にて静置した。
翌日、参考例1および参考例2で得たキウイフルーツ果
実の抽出物およびコーヒーノキ種子の抽出物をそれらの
最終濃度が0(対照)、キウイフルーツ果実の抽出物が
50,100μg/ml、およびコーヒーノキ種子の抽
出物が10,30μg/mlとなるように調整し、得ら
れた検体調製液を培地に添加し混和した。培養5日目に
培地を交換し、再度検体調製液を添加した。翌日、培地
を除き、1枚のシャーレについて、細胞をリン酸緩衝液
にて洗浄した後回収し、B16メラノーマ培養細胞の白
色化度を以下の基準にて評価した。Test Example 1 Test for inhibition of melanin production and cell viability by cell culture:
B16 melanoma cultured cells derived from mice were used as test cells, and melanin production inhibition and cell viability were examined. An appropriate amount of MEM medium supplemented with 10% FBS (manufactured by Nissui Pharmaceutical Co., Ltd.) was taken in two 6-well dishes, B16 melanoma cells were inoculated, and allowed to stand at 37 ° C. and 5% carbon dioxide concentration.
The next day, the kiwifruit fruit extract and the coffee tree seed extract obtained in Reference Examples 1 and 2 were brought to a final concentration of 0 (control), the kiwifruit fruit extract was 50,100 μg / ml, and the coffee tree was extracted. The seed extract was adjusted to be 10,30 μg / ml, and the obtained sample preparation was added to the medium and mixed. On the fifth day of the culture, the medium was replaced, and the sample preparation solution was added again. On the next day, the medium was removed, and one petri dish was washed with a phosphate buffer and then collected. The degree of whitening of the cultured B16 melanoma cells was evaluated according to the following criteria.
【0038】( 白色化度判定基準 ) < 判 定 > < 内 容 > ++ : 対照に対してきわめて白色である。 + : 対照に対してあきらかに白色である。 ± : 対照に対してやや白色である。 − : 対照と同じ黒色である。(Criteria for determining the degree of whitening) <Judgment> <Contents> ++: Very white with respect to the control. +: Clearly white with respect to the control. ±: slightly white with respect to the control. -: The same black color as the control.
【0039】残りの1枚のシャーレについて、細胞をホ
ルマリン固定後、1%クリスタルバイオレット溶液を添
加し染色した。各検体濃度に対する細胞生存率をモノセ
レーター(オリンパス社製)で測定した。生存率および
上で測定した白色化度の結果を表1に示す。For the remaining one petri dish, the cells were fixed in formalin and stained with a 1% crystal violet solution. Cell viability for each sample concentration was measured with a monocerator (Olympus). Table 1 shows the results of the viability and the degree of whitening measured above.
【0040】( 結 果 )(Result)
【表1】 [Table 1]
【0041】表1の結果から明らかなごとく、キウイフ
ルーツ果実の抽出物およびコーヒーノキ種子の抽出物は
いずれも高いメラニン生成抑制能を有し、かつB16メ
ラノーマ培養細胞に対し毒性が低いことが認められた。
さらにキウイフルーツ果実の抽出物とコーヒーノキ種子
の抽出物を組み合わせて添加することにより、細胞に毒
性を及ぼすことなく、メラニン生成抑制効果が相乗的に
高められることが認められた。従って、該植物抽出物を
配合した本発明の皮膚外用剤は、これを肌に適用するこ
とにより、極めて優れたメラニン生成抑制作用を発揮
し、日焼けによる肌の黒色化、シミおよびソバカスなど
を効果的に抑制し、美白・美肌効果が期待できる。As is evident from the results in Table 1, both the kiwifruit fruit extract and the coffee tree seed extract have high melanin production inhibitory activity and low toxicity on cultured B16 melanoma cells. Was.
Furthermore, it was confirmed that the combined addition of the extract of the kiwifruit fruit and the extract of the coffee tree seeds synergistically enhances the melanin production-inhibiting effect without causing cell toxicity. Therefore, the external preparation for skin of the present invention containing the plant extract exerts an extremely excellent melanin production inhibitory effect by applying it to the skin, and has an effect of blackening the skin due to sunburn, spots and freckles. It can be expected to have a whitening and skin effect.
【0042】実 施 例 1 クリーム:表2に示す組成及び下記製法でクリームを調
製し、キウイフルーツ果実の抽出物とコーヒーノキ種子
の抽出物の美白、美肌効果を調べた。この結果を表2に
示す。EXAMPLE 1 Cream: A cream was prepared according to the composition shown in Table 2 and by the following method, and the whitening and skin whitening effects of an extract of a kiwifruit fruit and an extract of a coffee tree seed were examined. Table 2 shows the results.
【0043】( 組成及び結果 )(Composition and Results)
【表2】 [Table 2]
【0044】( 製 法 ) A.成分(1)〜(6)、(11)、(13)、(1
4)、(16)、(17)を混合し、加熱して70℃に
保つ。 B.成分(19)の一部を加熱して70℃に保つ。 C.AにBを加え、(7)〜(9)、(18)および
(19)の残部で溶解した(10)、(12)、(1
5)を混合した後、冷却してクリームを得た。(Production method) Components (1) to (6), (11), (13), (1)
4), (16) and (17) are mixed and heated to 70 ° C. B. Heat a portion of component (19) and maintain at 70 ° C. C. B was added to A and dissolved in the remainder of (7) to (9), (18) and (19) (10), (12), (1)
After mixing 5), the mixture was cooled to obtain a cream.
【0045】( 試験方法 )被験クリーム1品につき2
7〜54才の女性15名をパネルとし、毎日朝と夜の2
回、12週間にわたって洗顔後に被験クリームの適量を
顔面に塗布した。塗布による美白・美肌効果を以下の基
準によって評価した。(Test method) 2 per test cream
A panel consisting of 15 women aged 7-54 years
After washing the face for 12 weeks, an appropriate amount of the test cream was applied to the face. The whitening and skin effect by coating were evaluated according to the following criteria.
【0046】 ( 評価基準 ) < 評 価 > < 内 容 > 有 効 : 肌のくすみが目立たなくなった。 やや有効 : 肌のくすみがあまり目立たなくなった。 無 効 : 使用前と変化なし。(Evaluation Criteria) <Evaluation> <Contents> Effective: The dullness of the skin became less noticeable. Slightly effective: Skin dullness became less noticeable. Ineffective: No change from before use.
【0047】表2の結果に示される如く、キウイフルー
ツ果実の抽出物とコーヒーノキ種子の抽出物を含まない
比較品1および4〜11や、キウイフルーツ果実の抽出
物およびコーヒーノキ種子の抽出物イをそれぞれ単独で
配合した比較例2,3と比べて、キウイフルーツ果実の
抽出物およびコーヒーノキ種子の抽出物を配合した本発
明品の外用剤は、これらを皮膚に適用することにより、
肌の「くすみ」等の発生の防止、改善することができ、
美しい肌とすることが明らかとなった。さらに、キウイ
フルーツ果実の抽出物およびコーヒーノキ種子の抽出物
と美白剤、抗酸化剤、抗炎症剤、紫外線防止剤、殺菌
剤、保湿剤および細胞補活剤を併用して配合した本発明
2〜9の外用剤組成物を皮膚に適用することにより、こ
れらの薬効剤を配合しない本発明1の外用剤を適用した
場合に比べて肌の「くすみ」等の発生の防止、改善効果
を相乗的に高め、美しい肌とすることが明らかとなっ
た。As shown in the results in Table 2, Comparative Examples 1 and 4 to 11 which did not contain the extract of the kiwifruit fruit and the extract of the coffee tree seeds, the extract of the kiwifruit fruit and the extract of the coffee tree seeds A In comparison with Comparative Examples 2 and 3, which were individually blended, the external preparation of the present invention containing the extract of the kiwifruit fruit and the extract of coffee tree seeds was applied to the skin by applying these to the skin.
Prevents and improves the appearance of skin dullness, etc.
It became clear to have beautiful skin. Furthermore, the present invention 2 to which an extract of kiwifruit fruit and an extract of coffee tree seeds are combined with a whitening agent, an antioxidant, an anti-inflammatory agent, an ultraviolet inhibitor, a bactericide, a humectant and a cell rejuvenating agent are combined. By applying the external preparation composition of No. 9 to the skin, the effect of preventing and improving the occurrence of “dullness” on the skin is more synergistic than in the case of applying the external preparation of the present invention 1 not containing these medicinal agents. It became clear that the skin was enhanced and beautiful.
【0048】 実 施 例 2 化粧水: ( 組 成 ) (%) (1)グリセリン 5.0 (2)1,3−ブチレングリコール 6.5 (3)ポリオキシエチレン(20E.O.) 1.2 ソルビタンモノラウリン酸エステル (4)エチルアルコール 8.0 (5)キウイフルーツ果実の抽出物*1 1.0 (6)コーヒーノキ種子の抽出物*2 1.0 (7)防腐剤 適量 (8)香料 適量 (9)精製水 残量 *1:参考例1で製造したもの *2:参考例2で製造したものExample 2 Lotion: (Composition) (%) (1) Glycerin 5.0 (2) 1,3-butylene glycol 6.5 (3) Polyoxyethylene (20EO) 2 Sorbitan monolaurate (4) Ethyl alcohol 8.0 (5) Kiwi fruit fruit extract * 1 1.0 (6) Coffee tree seed extract * 2 1.0 (7) Preservatives Appropriate amount (8) Fragrance Appropriate amount (9) Remaining purified water * 1: Manufactured in Reference Example 1 * 2: Manufactured in Reference Example 2
【0049】( 製 法 ) A.成分(3)、(4)、(7)及び(8)を混合溶解
する。 B.成分(1)、(2)、(5)、(6)及び(9)を
混合溶解する。 C.AとBを混合して均一にし、化粧水を得た。(Production method) Components (3), (4), (7) and (8) are mixed and dissolved. B. Components (1), (2), (5), (6) and (9) are mixed and dissolved. C. A and B were mixed and made uniform to obtain a lotion.
【0050】実施例2で得た化粧水は、経時安定性に優
れ、皮膚に適用することにより、日焼けによる肌の「く
すみ」やシミやソバカスを防止し、透明感のある美しい
肌にするものであった。The lotion obtained in Example 2 has excellent stability over time and, when applied to the skin, prevents "dullness" of the skin due to sunburn, spots and freckles, and gives a clear and beautiful skin. Met.
【0051】 実 施 例 3 乳液: ( 組 成 ) (%) (1)ポリオキシエチレン(10E.O.) 1.0 ソルビタンモノステアレート (2)ポリオキシエチレン(60E.O.) 0.5 ソルビットテトラオレエート (3)グリセリルモノステアレート 1.0 (4)ステアリン酸 0.5 (5)ベヘニルアルコール 0.5 (6)スクワラン 8.0 (7)キウイフルーツ果実の抽出物*1 3.0 (8)コーヒーノキ種子の抽出物*2 2.0 (9)胎盤抽出物*3 0.1 (10)酢酸dl−α−トコフェロール*4 0.05 (11)防腐剤 0.1 (12)カルボキシビニルポリマー 0.1 (13)水酸化ナトリウム 0.05 (14)エチルアルコール 5.0 (15)精製水 残量 (16)香料 適量 *1:参考例1で製造したもの *2:参考例2で製造したもの *3:ニチレイ社製 *4:エーザイ社製Example 3 Emulsion: (Composition) (%) (1) Polyoxyethylene (10EO) 1.0 Sorbitan monostearate (2) Polyoxyethylene (60EO) 0.5 Sorbit tetraoleate (3) Glyceryl monostearate 1.0 (4) Stearic acid 0.5 (5) Behenyl alcohol 0.5 (6) Squalane 8.0 (7) Kiwi fruit fruit extract * 1 3.0 (8) Coffee tree seed extract * 2 2.0 (9) Placenta extract * 3 0.1 (10) dl-α-tocopherol acetate * 4 0.05 (11) Preservative 0.1 (12) Carboxy Vinyl polymer 0.1 (13) Sodium hydroxide 0.05 (14) Ethyl alcohol 5.0 (15) Remaining purified water (16) Appropriate perfume * 1: Produced in Reference Example 1 2: those that have been prepared in Reference Example 2 * 3: Nichirei * 4: Eisai Co., Ltd.
【0052】( 製 法 ) A.成分(12)〜(15)を加熱混合し、70℃に保
つ。 B.成分(1)〜(6)および(10)を加熱混合し、
70℃に保つ。 C.BにAを加えて混合し、均一に乳化する。 D.Cを冷却後(7)〜(9)、(11)および(1
6)を加え、均一に混合して乳液を得た。(Production method) The components (12) to (15) are mixed by heating and kept at 70 ° C. B. Heating and mixing components (1) to (6) and (10),
Keep at 70 ° C. C. Add A to B, mix and emulsify uniformly. D. After cooling C, (7) to (9), (11) and (1)
6) was added and mixed uniformly to obtain an emulsion.
【0053】実施例3で得た乳液は、キウイフルーツ果
実の抽出物、コーヒーノキ種子の抽出物、胎盤抽出物お
よび酢酸dl−α−トコフェロールを併用することによ
り、日焼けによる肌の「くすみ」やシミやソバカスを防
止し、透明感のある美しい肌にする効果がより優れたも
のであった。The emulsion obtained in Example 3 was used in combination with the extract of kiwifruit fruit, the extract of coffee tree seeds, the extract of placenta and the dl-α-tocopherol acetate to obtain “stained skin” and stains due to sunburn. The effect of preventing skin flecks and freckles and making the skin beautiful and transparent was more excellent.
【0054】 実 施 例 4 軟膏: ( 処 方 ) (%) (1)ステアリン酸 18.0 (2)セタノール 4.0 (3)トリエタノールアミン 2.0 (4)グリセリン 5.0 (5)キウイフルーツ果実の抽出物*1 1.0 (6)コーヒーノキ種子の抽出物*2 0.1 (7)グリチルリチン酸ジカリウム*3 0.1 (8)乳酸*4 0.2 (9)精製水 残量 *1:参考例1で製造したもの *2:参考例2で製造したもの *3:丸善製薬社製 *4:第一製薬社製Example 4 Ointment: (Prescription) (%) (1) Stearic acid 18.0 (2) Cetanol 4.0 (3) Triethanolamine 2.0 (4) Glycerin 5.0 (5) Kiwifruit fruit extract * 1 1.0 (6) Coffee tree seed extract * 2 0.1 (7) Dipotassium glycyrrhizinate * 3 0.1 (8) Lactic acid * 4 0.2 (9) Purified water residue Amount * 1: Manufactured in Reference Example 1 * 2: Manufactured in Reference Example 2 * 3: Maruzen Pharmaceutical Co., Ltd. * 4: Daiichi Pharmaceutical Co., Ltd.
【0055】( 製 法 ) A.成分(3)、(4)、(8)及び(9)の一部を加
熱混合し、75℃に保つ。 B.成分(1)、(2)を加熱混合し、75℃に保つ。 C.AをBに徐々に加える。 D.Cを冷却しながら(5)、(6)および(9)の残
部で溶解した(7)を加え、軟膏を得た。(Production method) A. A part of the components (3), (4), (8) and (9) are mixed by heating and kept at 75 ° C. B. Heat and mix components (1) and (2) and maintain at 75 ° C. C. Add A slowly to B. D. While cooling C, (7) dissolved in the rest of (5), (6) and (9) was added to obtain an ointment.
【0056】実施例4で得た軟膏は経時安定性に優れ、
キウイフルーツ果実の抽出物とコーヒーノキ種子の抽出
物とグリチルリチン酸ジカリウムおよび乳酸とを併用す
ることにより「くすみ」やシミやソバカスを防止し、よ
り透明感のある美しい肌にするものであった。The ointment obtained in Example 4 has excellent stability over time,
By using an extract of a kiwifruit fruit, an extract of a coffee tree seed, and dipotassium glycyrrhizinate and lactic acid together, it was possible to prevent "dullness", spots and freckles, and to make the skin more transparent and beautiful.
【0057】 実 施 例 5 パック: ( 処 方 ) (%) (1)ポリビニルアルコール 20.0 (2)エチルアルコール 20.0 (3)グリセリン 5.0 (4)カオリン 6.0 (5)キウイフルーツ果実の抽出物*1 1.0 (6)コーヒーノキ種子の抽出物*2 1.0 (7)グリチルレチン酸ステアリル*3 0.1 (8)酢酸dl−α−トコフェロール*4 0.2 (9)小麦胚芽抽出物*5 1.0 (10)防腐剤 0.2 (11)香料 0.1 (12)精製水 残量 *1:参考例1で製造したもの *2:参考例2で製造したもの *3:丸善製薬社製 *4:エーザイ社製 *5:SILAB社製Example 5 Pack: (Preparation) (%) (1) Polyvinyl alcohol 20.0 (2) Ethyl alcohol 20.0 (3) Glycerin 5.0 (4) Kaolin 6.0 (5) Kiwi Fruit fruit extract * 1 1.0 (6) Coffee tree seed extract * 2 1.0 (7) Stearyl glycyrrhetinate * 3 0.1 (8) dl-α-tocopherol acetate * 4 0.2 (9 ) Wheat germ extract * 5 1.0 (10) Preservative 0.2 (11) Perfume 0.1 (12) Purified water Remaining * 1: Manufactured in Reference Example 1 * 2: Manufactured in Reference Example 2 * 3: Maruzen Pharmaceutical Co., Ltd. * 4: Eisai Co., Ltd. * 5: SILAB Co., Ltd.
【0058】( 製 法 ) A.成分(1)、(3)、(4)及び(12)を混合
し、70℃に加熱し、撹拌する。 B.成分(2)、(7)、(8)及び(10)を混合す
る。 C.上記Bを先のAに加え、混合した後、冷却して
(5)、(6)、(9)及び(11)を均一に分散して
パックを得た。(Production method) Mix components (1), (3), (4) and (12), heat to 70 ° C. and stir. B. Mix components (2), (7), (8) and (10). C. The above B was added to the above A, mixed, cooled, and (5), (6), (9) and (11) were uniformly dispersed to obtain a pack.
【0059】実施例5で得たパックは経時安定性に優
れ、皮膚に適用することにより、肌の「くすみ」やシミ
を防止し、透明感のある美しい肌にするものであった。The pack obtained in Example 5 was excellent in stability over time and, when applied to the skin, prevented "smearing" and spots on the skin, and made the skin transparent and beautiful.
【0060】 実 施 例 6 リキッドファンデーション: ( 処 方 ) (%) (1)ラノリン 7.0 (2)流動パラフィン 5.0 (3)ステアリン酸 2.0 (4)セタノール 1.0 (5)パラメトキシケイ皮酸 3.0 −2−エチルヘキシル*1 (6)グリセリン 5.0 (7)トリエタノールアミン 1.0 (8)カルボキシメチルセルロース 0.7 (9)精製水 残量 (10)酸化チタン 8.0 (11)微粒子酸化チタン 2.0 (12)酸化亜鉛 5.0 (13)マイカ 15.0 (14)タルク 6.0 (15)着色顔料 6.0 (16)キウイフルーツ果実の抽出物*2 0.01 (17)コーヒーノキの抽出物*3 0.05 (18)プルーン抽出物*4 0.5 (19)香料 適量 *1:BASF社製 *2:参考例1で製造したもの *3:参考例2で製造したもの *4:丸善製薬社製Example 6 Liquid foundation: (Preparation) (%) (1) Lanolin 7.0 (2) Liquid paraffin 5.0 (3) Stearic acid 2.0 (4) Cetanol 1.0 (5) Paramethoxycinnamic acid 3.0-2-ethylhexyl * 1 (6) Glycerin 5.0 (7) Triethanolamine 1.0 (8) Carboxymethylcellulose 0.7 (9) Purified water Remaining (10) Titanium oxide 8.0 (11) Fine particle titanium oxide 2.0 (12) Zinc oxide 5.0 (13) Mica 15.0 (14) Talc 6.0 (15) Color pigment 6.0 (16) Kiwi fruit fruit extraction things * 2 0.01 (17) Coffea extract * 3 0.05 (18) prune extract * 4 0.5 (19) perfume Appropriate amount * 1: BASF Co. * 2: prepared in reference example 1 Roh * 3: those that have been prepared in Reference Example 2 * 4: Maruzen Pharmaceuticals Co., Ltd.
【0061】( 製 法 ) A.成分(1)〜(5)を混合溶解する。 B.Aに成分(10)〜(15)を加え、均一に混合
し、70℃に保つ。 C.成分(6)〜(9)を均一に溶解し、70℃に保
つ。 D.BにCを添加して、均一に乳化する。 E.Dを冷却後、成分(16)〜(19)を添加してリ
キッドファンデーションを得た。(Production method) Components (1) to (5) are mixed and dissolved. B. Add components (10) to (15) to A, mix uniformly, and keep at 70 ° C. C. Components (6) to (9) are uniformly dissolved and kept at 70 ° C. D. Add C to B and emulsify uniformly. E. FIG. After cooling D, components (16) to (19) were added to obtain a liquid foundation.
【0062】実施例6のキウイフルーツ果実の抽出物と
コーヒーノキ種子の抽出物、パラメトキシケイ皮酸−2
−エチルへキシルおよびプルーン抽出物を併用したリキ
ッドファンデーションは、経時安定性に優れ、皮膚に適
用することにより、日焼け等による肌の黒化やシミやソ
バカスを防止する効果に非常に優れるものであった。[0062] Kiwifruit fruit extract and coffee tree seed extract of Example 6, paramethoxycinnamic acid-2
-A liquid foundation using ethylhexyl and prune extract in combination has excellent stability over time, and when applied to the skin, is extremely excellent in preventing skin darkening due to sunburn and preventing spots and freckles. Was.
【0063】[0063]
【発明の効果】以上のごとく、本発明のキウイフルーツ
果実の抽出物およびコーヒーノキ種子の抽出物を含有す
る皮膚外用剤は、メラニン生成抑制作用を有しており、
色素沈着に対し高い抑制効果を発揮し、肌のくすみ、日
やけなどによる皮膚の黒化、シミ、ソバカスの防止及び
改善等に有効である。As described above, the external preparation for skin containing the kiwifruit fruit extract and the coffee tree seed extract of the present invention has a melanin production inhibitory action,
It exerts a high inhibitory effect on pigmentation and is effective in preventing and improving skin darkening due to dull skin, sunburn, etc., spots and freckles.
【0064】また、キウイフルーツ果実の抽出物とコー
ヒーノキ種子の抽出物のほか、美白剤、抗酸化剤、抗炎
症剤、紫外線防止剤、殺菌剤、保湿剤および細胞賦活剤
等の他の薬効成分を配合した本発明の皮膚外用剤組成物
は、前記抽出物を単独で配合した場合に比べより優れた
美白・美肌効果を有するものである。In addition to the extract of kiwifruit fruit and the extract of coffee tree seeds, other medicinal ingredients such as whitening agents, antioxidants, anti-inflammatory agents, ultraviolet inhibitors, bactericides, moisturizers and cell activators. The skin external preparation composition of the present invention, which contains the above-mentioned extract, has more excellent whitening and skin effect than the case where the above-mentioned extract is used alone.
【0065】従って、本発明皮膚外用剤および皮膚外用
剤組成物は、美白、美肌を目的とする化粧品や医薬等と
して有利に利用することができるものである 以上Accordingly, the external preparation for skin and the external composition for skin of the present invention can be advantageously used as cosmetics and medicines for whitening and beautiful skin.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 7/00 A61K 7/00 U 35/78 35/78 W A61P 17/16 A61P 17/16 Fターム(参考) 4C083 AA072 AA082 AA111 AA112 AB032 AB212 AB242 AB432 AB442 AC012 AC022 AC072 AC102 AC122 AC242 AC302 AC342 AC422 AC442 AC472 AC542 AC642 AD092 AD112 AD272 AD532 AD622 AD642 AD662 BB46 BB47 BB48 BB51 CC04 CC05 CC07 CC12 DD22 EE12 EE16 4C088 AB12 AB14 AC04 CA05 CA06 CA08 MA07 MA63 NA14 ZA89 ZC41 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) A61K 7/00 A61K 7/00 U 35/78 35/78 W A61P 17/16 A61P 17/16 F term ( Reference) 4C083 AA072 AA082 AA111 AA112 AB032 AB212 AB242 AB432 AB442 AC012 AC022 AC072 AC102 AC122 AC242 AC302 AC342 AC422 AC442 AC472 AC542 AC642 AD092 AD112 AD272 AD532 AD622 AD642 AD662 BB46 BB47 BB48 BB51 CC04 CC05 CC07 CC12 AB14 MA07 MA63 NA14 ZA89 ZC41
Claims (2)
抽出物 (B)アカネ科、コーヒーノキ属のコーヒーノキ種子の
抽出物を含有することを特徴とする皮膚外用剤。1. The following components (A) and (B): (A) an extract of a kiwi fruit fruit belonging to the family Rubiaceae and Rubiaceae; External preparation for skin.
抽出物 (B)アカネ科、コーヒーノキ属のコーヒーノキ種子の
抽出物 (C)美白剤、抗酸化剤、抗炎症剤、紫外線防止剤、殺
菌剤、保湿剤及び細胞賦活剤から選ばれる薬効剤の一種
又は二種以上を含有することを特徴とする皮膚外用剤組
成物。2. The following components (A), (B) and (C): (A) an extract of the fruit of the genus Agariidae and the kiwi fruit of the genus Agaricus (B); A skin external preparation composition comprising one or more active agents selected from whitening agents, antioxidants, anti-inflammatory agents, ultraviolet inhibitors, bactericides, humectants, and cell activators.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000180375A JP4088021B2 (en) | 2000-06-15 | 2000-06-15 | Skin external preparation and skin external preparation composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000180375A JP4088021B2 (en) | 2000-06-15 | 2000-06-15 | Skin external preparation and skin external preparation composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001354545A true JP2001354545A (en) | 2001-12-25 |
| JP4088021B2 JP4088021B2 (en) | 2008-05-21 |
Family
ID=18681490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000180375A Expired - Fee Related JP4088021B2 (en) | 2000-06-15 | 2000-06-15 | Skin external preparation and skin external preparation composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4088021B2 (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005034900A1 (en) * | 2003-10-06 | 2005-04-21 | Henkel Kommanditgesellschaft Auf Aktien | Cosmetic or pharmaceutical preparations containing oligo and/or polysaccharides for the treatment of epithelial covering tissue |
| JP2008214272A (en) * | 2007-03-05 | 2008-09-18 | Oriza Yuka Kk | Whitening agent |
| JP2010120876A (en) * | 2008-11-19 | 2010-06-03 | Maruzen Pharmaceut Co Ltd | TYPE I COLLAGEN PRODUCTION PROMOTER, ADENOSINE TRIPHOSPHATE PRODUCTION PROMOTER, GLUTATHIONE PRODUCTION PROMOTER, FILAGGRIN PRODUCTION PROMOTER, MELANIN PRODUCTION INHIBITOR, BASIC FIBROBLAST GROWTH FACTOR (bFGF) mRNA EXPRESSION INHIBITOR AND TRANSPARENCY-IMPROVING AGENT FOR SKIN |
| US8597710B2 (en) | 2003-04-16 | 2013-12-03 | Vdf Futureceuticals, Inc. | Low-mycotoxin coffee cherry products |
| US8603563B2 (en) | 2003-04-16 | 2013-12-10 | Vdf Futureceuticals, Inc. | Methods for coffee cherry products |
| JP2015160821A (en) * | 2014-02-26 | 2015-09-07 | 共栄化学工業株式会社 | Whitening composition and cosmetic |
| US10653614B2 (en) | 2004-04-08 | 2020-05-19 | Vdf Futureceuticals, Inc. | Coffee cherry cosmetic composition and methods |
-
2000
- 2000-06-15 JP JP2000180375A patent/JP4088021B2/en not_active Expired - Fee Related
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8597710B2 (en) | 2003-04-16 | 2013-12-03 | Vdf Futureceuticals, Inc. | Low-mycotoxin coffee cherry products |
| US8603563B2 (en) | 2003-04-16 | 2013-12-10 | Vdf Futureceuticals, Inc. | Methods for coffee cherry products |
| US8603564B2 (en) | 2003-04-16 | 2013-12-10 | Vdf Futureceuticals, Inc. | Low-mycotoxin coffee cherry products |
| US9888702B2 (en) | 2003-04-16 | 2018-02-13 | Vdf Futureceuticals | Low-mycotoxin coffee cherry products |
| US9930900B2 (en) | 2003-04-16 | 2018-04-03 | Vdf Futureceuticals, Inc. | Low-mycotoxin coffee cherry products |
| US10238128B2 (en) | 2003-04-16 | 2019-03-26 | Vdf Futureceuticals, Inc. | Low-mycotoxin coffee cherry products |
| WO2005034900A1 (en) * | 2003-10-06 | 2005-04-21 | Henkel Kommanditgesellschaft Auf Aktien | Cosmetic or pharmaceutical preparations containing oligo and/or polysaccharides for the treatment of epithelial covering tissue |
| US10653614B2 (en) | 2004-04-08 | 2020-05-19 | Vdf Futureceuticals, Inc. | Coffee cherry cosmetic composition and methods |
| JP2008214272A (en) * | 2007-03-05 | 2008-09-18 | Oriza Yuka Kk | Whitening agent |
| JP2010120876A (en) * | 2008-11-19 | 2010-06-03 | Maruzen Pharmaceut Co Ltd | TYPE I COLLAGEN PRODUCTION PROMOTER, ADENOSINE TRIPHOSPHATE PRODUCTION PROMOTER, GLUTATHIONE PRODUCTION PROMOTER, FILAGGRIN PRODUCTION PROMOTER, MELANIN PRODUCTION INHIBITOR, BASIC FIBROBLAST GROWTH FACTOR (bFGF) mRNA EXPRESSION INHIBITOR AND TRANSPARENCY-IMPROVING AGENT FOR SKIN |
| JP2015160821A (en) * | 2014-02-26 | 2015-09-07 | 共栄化学工業株式会社 | Whitening composition and cosmetic |
Also Published As
| Publication number | Publication date |
|---|---|
| JP4088021B2 (en) | 2008-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20010057585A (en) | External preparation for skin | |
| JP2000229828A (en) | Skin bleaching lotion | |
| JP3851750B2 (en) | Topical skin preparation | |
| JP2001261570A (en) | Skin care preparation | |
| JP2001181173A (en) | Bleaching preparation for external use | |
| JP2001220340A (en) | Skin preparation for external use for preventing aging | |
| JPH049316A (en) | Whitening cosmetic | |
| JP2002138027A (en) | External preparation for skin | |
| JP4088021B2 (en) | Skin external preparation and skin external preparation composition | |
| JP2001335497A (en) | Skin care preparation and skin care preparation composition | |
| JP4203325B2 (en) | Skin external preparation and skin external preparation composition | |
| JP2001261548A (en) | Skin care preparation | |
| JP2003252742A (en) | Melanocyte dendrite formation inhibitor and skin care preparation containing the same | |
| JP3754646B2 (en) | Topical skin preparation | |
| JP2004051492A (en) | Antiaging agent or cell activator and external preparation for skin comprising the same | |
| JP2001322941A (en) | External preparation for skin | |
| JP2002145752A (en) | Skin external preparation and skin external composition | |
| JP2002020232A (en) | Skin care preparation and skin care composition | |
| JP2010150173A (en) | Skin whitening agent, melanogenesis inhibitor, and skin whitening skin external preparation | |
| JPH05194175A (en) | Cosmetic | |
| JP2001181170A (en) | Skin care preparation | |
| JP5349719B2 (en) | Topical skin preparation | |
| JP2009256326A (en) | Skin whitening preparation, and skincare preparation | |
| JP2001261523A (en) | Skin care preparation | |
| JP3946418B2 (en) | Melanin production inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060213 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20070523 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070605 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070802 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20070802 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20070802 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080205 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080222 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110228 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4088021 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140228 Year of fee payment: 6 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |